Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Biomarkers Are Specific for Fatal Genetic Disorder

By LabMedica International staff writers
Posted on 16 Nov 2010
A simple blood test can help diagnose the rare progressive neurodegenerative disorder Niemann-Pick type C 1 (NPC1) disease. More...


NPC 1 disease is characterized by accumulation of cholesterol in the endolysosomes and by measuring these metabolites in plasma a definitive diagnosis of the disease can be made. Endolysosomes are the products of the fusion of an endosome and a lysosome during endocytosis.

In a collaborative study carried out at the Washington University School of Medicine (St. Louis, MO, USA), scientists evaluated the level of these oxidized forms of cholesterol in human plasma and tissue and animal models.

Nonenzymatically formed cholesterol oxidation products were increased in the plasma of all human NPC1 subjects studied and delineated an oxysterol profile specific for NPC1 disease. The oxysterol profile also correlated with the age of disease onset and disease severity. They further showed that the plasma oxysterol markers decreased in response to an established therapeutic intervention in the NPC1 feline model. The oxysterol profiles were obtained using gas chromatography and mass spectrometry (GC/MS) techniques.

Although no group that scientists screened had levels of the two key markers as high as the NPC patients, the markers were significantly increased in parents and siblings of NPC patients. Many of these family members have one mutated NPC gene and are carriers of the disease. In NPC patients, two oxidized forms of cholesterol were present at levels 9 to 10 times higher than normal. The same markers were not elevated in healthy children and adults or in persons with elevated cholesterol levels, heart disease, diabetes or other forms of lysosomal storage disorders.

NPC typically manifests in childhood with a variety of symptoms including problems walking, slurring of speech and difficulty swallowing. In later stages, it immobilizes patients, causing seizures, dementia, and death. NPC belongs to a class of inherited diseases known as lysosomal storage disorders. The disorder breaks down the cell's normal patterns for handling cholesterol, leading it to accumulate in lysosomes, the cellular organelles, which contain acid hydrolase enzymes that break up waste materials and cellular debris.

Daniel S. Ory, M.D., one of the senior authors, said, "This is an important step forward both in terms of making a definitive diagnosis much easier and in terms of providing us with a way to quickly assess the effectiveness of experimental treatments."

The study was published November 3, 2010 in the journal Science Translational Medicine.

Related Links:

Washington University School of Medicine




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Gold Member
Platelet Function Analyzer
PL-12
Gold Member
Automatic Hematology Analyzer
CF9600
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.